Leptomeningeal Disease Recruiting Phase 1 Trials for Avelumab (DB11945)

Also known as: Metastases to meninges / Malignant meningitis / Meningeal Carcinomatosis

IndicationStatusPhase
DBCOND0075962 (Leptomeningeal Disease)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03719768Avelumab With Radiotherapy in Patients With Leptomeningeal DiseaseTreatment